GYRE logo

Gyre Therapeutics (GYRE) EBIT

Annual EBIT

$19.21 M
+$10.01 M+108.77%

December 31, 2023


Summary


Performance

GYRE EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREprofitabilitymetrics:

Quarterly EBIT

$4.23 M
+$971.00 K+29.77%

September 30, 2024


Summary


Performance

GYRE Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREprofitabilitymetrics:

TTM EBIT

$10.38 M
-$8.53 M-45.12%

September 30, 2024


Summary


Performance

GYRE TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GYRE EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+108.8%+181.6%-46.0%
3 y3 years-35.4%-36.5%+55.7%
5 y5 years-35.4%-36.5%+55.7%

GYRE EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.4%+108.8%-66.8%+181.6%-57.5%+55.7%
5 y5-year-35.4%+108.8%-66.8%+181.6%-57.5%+55.7%
alltimeall time-35.4%+108.8%-66.8%+181.6%-57.5%+55.7%

Gyre Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.23 M(+29.8%)
$10.38 M(-45.1%)
Jun 2024
-
$3.26 M(-59.6%)
$18.91 M(-8.3%)
Mar 2024
-
$8.07 M(-255.5%)
$20.62 M(+7.3%)
Dec 2023
$19.21 M
-$5.19 M(-140.7%)
$19.21 M(-21.3%)
Sep 2023
-
$12.76 M(+156.6%)
$24.40 M(+109.7%)
DateAnnualQuarterlyTTM
Jun 2023
-
$4.97 M(-25.4%)
$11.64 M(+74.6%)
Mar 2023
-
$6.66 M(-16.1%)
$6.66 M(-16.1%)
Dec 2022
$9.20 M(-69.0%)
-
-
Mar 2022
-
$7.95 M
$7.95 M
Dec 2021
$29.73 M
-
-

FAQ

  • What is Gyre Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Gyre Therapeutics?
  • What is Gyre Therapeutics annual EBIT year-on-year change?
  • What is Gyre Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Gyre Therapeutics?
  • What is Gyre Therapeutics quarterly EBIT year-on-year change?
  • What is Gyre Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Gyre Therapeutics?
  • What is Gyre Therapeutics TTM EBIT year-on-year change?

What is Gyre Therapeutics annual earnings before interest & taxes?

The current annual EBIT of GYRE is $19.21 M

What is the all time high annual EBIT for Gyre Therapeutics?

Gyre Therapeutics all-time high annual earnings before interest & taxes is $29.73 M

What is Gyre Therapeutics annual EBIT year-on-year change?

Over the past year, GYRE annual earnings before interest & taxes has changed by +$10.01 M (+108.77%)

What is Gyre Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of GYRE is $4.23 M

What is the all time high quarterly EBIT for Gyre Therapeutics?

Gyre Therapeutics all-time high quarterly earnings before interest & taxes is $12.76 M

What is Gyre Therapeutics quarterly EBIT year-on-year change?

Over the past year, GYRE quarterly earnings before interest & taxes has changed by +$9.42 M (+181.58%)

What is Gyre Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of GYRE is $10.38 M

What is the all time high TTM EBIT for Gyre Therapeutics?

Gyre Therapeutics all-time high TTM earnings before interest & taxes is $24.40 M

What is Gyre Therapeutics TTM EBIT year-on-year change?

Over the past year, GYRE TTM earnings before interest & taxes has changed by -$8.84 M (-45.99%)